Casualties outnumber caregivers
Teams must maintain awareness, identify priorities and allocate limited attention across several patients at the same time.
Dual-use medical technology
Harptek is developing novel medical devices and clinical decision-support tools for critically ill and injured patients in austere, disrupted and resource-constrained environments. Working prototypes already demonstrate significant progress toward a connected Human Survivability Ecosystem.
The challenge
Combat, disasters, mass-casualty events and pandemics share a common operational problem: the number of people requiring rapid, correct care can rise faster than experienced personnel, equipment and evacuation capacity.
Teams must maintain awareness, identify priorities and allocate limited attention across several patients at the same time.
Delayed evacuation, limited resources and unreliable communications can extend care far beyond the initial response.
Physiological trends and care context must remain available as personnel, locations, platforms and connectivity change.
Human Survivability Ecosystem
The ecosystem is designed around four complementary capabilities, while individual components can also be deployed independently for selected use cases.
Physiological information and trends available close to the point of care.
Offline-capable support designed for time-critical and resource-constrained workflows.
Structured information retained across changing teams, locations and communications.
Remote clinical oversight and communication where appropriate and available.
Dual-use applications
Intended application areas include combat and TCCC, mass-casualty events, disasters and pandemics—settings where delayed evacuation, prolonged care and constrained communications can directly affect outcomes.
Selected components can support supervised exercise planning, athlete monitoring and remote follow-up without the operational complexities of combat environments.
Contact
Harptek is open to discussions on integration, joint development, technical and clinical collaboration, and selected dual-use deployment opportunities.